retatrutide and perimenopause Reta Weight Loss: Phase 3 Trial Data What Patients Actually Report in 2026 Retatrutide Benefits for Women: Evidence,
Description
GLP-1RAs impact gastric, intestinal, and gallbladder motility, which can be beneficial (eg, through slowing glucose and lipid entry into the circulation after meals) but may also increase the risk of adverse consequences (eg, retained gastric contents, potentially resulting in pulmonary aspiration during endoscopy or induction of general anesthesia and gallbladder and biliary complications)

The additional receptor activation produces continued weight loss without proportionally increased nausea

Tirzepatide is another weight loss injection that is also a dual agonist, meaning it targets both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors

Available from: Kosiborod MN, Bhatta M, Davies M, Deanfield JE, Garvey WT, Khalid U, Kushner R, Rubino DM, Zeuthen N, Verma S

Severe or persistent dry mouth that does not improve with conservative measures may benefit from prescription interventions or evaluation for other contributing factors beyond medication effects
Every 0.1mL contains exactly 0.2mg
